Zenas BioPharma, Inc. Common Stock (ZBIO) — Defensive Interval Ratio
Zenas BioPharma, Inc. Common Stock (ZBIO) has a Defensive Interval Ratio of 1301 days as of March 2026. Defensive assets of $218.08 Million (cash $-, short-term investments $216.98 Million, receivables $1.10 Million) cover 1301 days of daily cash needs of $167.56K/day. See ZBIO working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Zenas BioPharma, Inc. Common Stock Defensive Interval Ratio (2023–2025)
This chart shows how Zenas BioPharma, Inc. Common Stock's Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of March 2026, the ratio stands at 1301 days, meaning defensive assets of $218.08 Million can fund 1301 days of operations without new revenue. See Zenas BioPharma, Inc. Common Stock (ZBIO) net asset quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Zenas BioPharma, Inc. Common Stock (2023–2025)
The table below presents the year-by-year Defensive Interval Ratio for Zenas BioPharma, Inc. Common Stock from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see ZBIO market cap overview.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1355 days | $232.55 Million | $171.64K/day | $- | $232.55 Million | ▲ +1157 days |
| 2024 | 198 days | $31.02 Million | $156.96K/day | $- | $31.02 Million | ▲ +198 days |
| 2023 | 0 days | $0.00 | $63.72K/day | $- | $0.00 | — |